Drug Shortage Report for SANDOZ GLICLAZIDE MR

Last updated on 2022-02-18 History
Report ID 154517
Drug Identification Number 02461331
Brand name SANDOZ GLICLAZIDE MR
Common or Proper name GLICLAZIDE
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) GLICLAZIDE
Strength(s) 60MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 100MRT BO
ATC code A10BB
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2022-02-08
Estimated end date 2022-02-25
Actual end date 2022-02-17
Shortage status Resolved
Updated date 2022-02-18
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2022-02-18 English Compare
v4 2022-02-17 French Compare
v3 2022-02-17 English Compare
v2 2022-02-08 French Compare
v1 2022-02-08 English Compare

Showing 1 to 5 of 5